320 related articles for article (PubMed ID: 31849915)
1. K5 Capsule and Lipopolysaccharide Are Important in Resistance to T4 Phage Attack in Probiotic
Soundararajan M; von Bünau R; Oelschlaeger TA
Front Microbiol; 2019; 10():2783. PubMed ID: 31849915
[TBL] [Abstract][Full Text] [Related]
2. The Probiotic
Bury S; Soundararajan M; Bharti R; von Bünau R; Förstner KU; Oelschlaeger TA
Front Microbiol; 2018; 9():929. PubMed ID: 29896160
[TBL] [Abstract][Full Text] [Related]
3. Prospective and challenges of live bacterial therapeutics from a superhero
Effendi SSW; Ng IS
Crit Rev Microbiol; 2023 Sep; 49(5):611-627. PubMed ID: 35947523
[No Abstract] [Full Text] [Related]
4. More than a marine propeller--the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus.
Troge A; Scheppach W; Schroeder BO; Rund SA; Heuner K; Wehkamp J; Stange EF; Oelschlaeger TA
Int J Med Microbiol; 2012 Dec; 302(7-8):304-14. PubMed ID: 23131416
[TBL] [Abstract][Full Text] [Related]
5. Adaptive Strategies of the Candidate Probiotic E. coli Nissle in the Mammalian Gut.
Crook N; Ferreiro A; Gasparrini AJ; Pesesky MW; Gibson MK; Wang B; Sun X; Condiotte Z; Dobrowolski S; Peterson D; Dantas G
Cell Host Microbe; 2019 Apr; 25(4):499-512.e8. PubMed ID: 30926240
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of phosphoethanolamine-modified lipid A from probiotic
Jo SH; Park HG; Song WS; Kim SM; Kim EJ; Yang YH; Kim JS; Kim BG; Kim YG
RSC Adv; 2019 Jun; 9(34):19762-19771. PubMed ID: 35519361
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection.
Sabharwal H; Cichon C; Ölschläger TA; Sonnenborn U; Schmidt MA
Infect Immun; 2016 Sep; 84(9):2482-92. PubMed ID: 27297392
[TBL] [Abstract][Full Text] [Related]
8. High density fermentation of probiotic E. coli Nissle 1917 towards heparosan production, characterization, and modification.
Datta P; Fu L; Brodfuerer P; Dordick JS; Linhardt RJ
Appl Microbiol Biotechnol; 2021 Feb; 105(3):1051-1062. PubMed ID: 33481068
[TBL] [Abstract][Full Text] [Related]
9. Escherichia coli Nissle 1917 for probiotic use in piglets: evidence for intestinal colonization.
Barth S; Duncker S; Hempe J; Breves G; Baljer G; Bauerfeind R
J Appl Microbiol; 2009 Nov; 107(5):1697-710. PubMed ID: 19457029
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of bacterial swimming by heparin binding of flagellin FliC from Escherichia coli strain Nissle 1917.
Yang G; Yang L; Zhou X
Arch Microbiol; 2023 Jul; 205(8):286. PubMed ID: 37452842
[TBL] [Abstract][Full Text] [Related]
11. Disruption of Escherichia coli Nissle 1917 K5 capsule biosynthesis, through loss of distinct kfi genes, modulates interaction with intestinal epithelial cells and impact on cell health.
Nzakizwanayo J; Kumar S; Ogilvie LA; Patel BA; Dedi C; Macfarlane WM; Jones BV
PLoS One; 2015; 10(3):e0120430. PubMed ID: 25790373
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
[TBL] [Abstract][Full Text] [Related]
13. Decolonizing drug-resistant
Forsyth JH; Barron NL; Scott L; Watson BNJ; Chisnall MAW; Meaden S; van Houte S; Raymond B
Microbiology (Reading); 2023 Jul; 169(7):. PubMed ID: 37418300
[TBL] [Abstract][Full Text] [Related]
14. Decisive role of lipopolysaccharide in activating nitric oxide and cytokine production by the probiotic Escherichia coli strain Nissle 1917.
Zídek Z; Kmonícková E; Kostecká P; Tlaskalová-Hogenová H
Folia Microbiol (Praha); 2010 Mar; 55(2):181-9. PubMed ID: 20490762
[TBL] [Abstract][Full Text] [Related]
15. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
[TBL] [Abstract][Full Text] [Related]
16. Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917.
Trebichavsky I; Splichal I; Rada V; Splichalova A
Nutr Rev; 2010 Aug; 68(8):459-64. PubMed ID: 20646223
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory modulation of immune response by probiotic Escherichia coli Nissle 1917 in human blood mononuclear cells.
Güttsches AK; Löseke S; Zähringer U; Sonnenborn U; Enders C; Gatermann S; Bufe A
Innate Immun; 2012 Apr; 18(2):204-16. PubMed ID: 21382908
[TBL] [Abstract][Full Text] [Related]
18. Effect of antibiotic, probiotic, and human rotavirus infection on colonisation dynamics of defined commensal microbiota in a gnotobiotic pig model.
Huang HC; Vlasova AN; Kumar A; Kandasamy S; Fischer DD; Deblais L; Paim FC; Langel SN; Alhamo MA; Rauf A; Shao L; Saif LJ; Rajashekara G
Benef Microbes; 2018 Jan; 9(1):71-86. PubMed ID: 29022385
[TBL] [Abstract][Full Text] [Related]
19. Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.
Scaldaferri F; Gerardi V; Mangiola F; Lopetuso LR; Pizzoferrato M; Petito V; Papa A; Stojanovic J; Poscia A; Cammarota G; Gasbarrini A
World J Gastroenterol; 2016 Jun; 22(24):5505-11. PubMed ID: 27350728
[TBL] [Abstract][Full Text] [Related]
20. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
